Gabriel Johnson
Physician Assistant · Boca Raton, FLNPI 1124578331
Payments from drug & device makers
Across 256 payments — averaging $18.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$799
- Amgen$652
- Pfizer$422
- Novo Nordisk$418
- Bayer$317
- Lilly USA, LLC$314
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,809100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 45 | $799 |
| Amgen | 38 | $652 |
| Pfizer | 19 | $422 |
| Novo Nordisk | 23 | $418 |
| Bayer | 13 | $317 |
| Lilly USA, LLC | 17 | $314 |
| AstraZeneca | 18 | $297 |
| Novartis | 13 | $250 |
| Boehringer Ingelheim | 8 | $172 |
| Amarin Pharma, Inc. | 11 | $170 |
| Exact Sciences | 9 | $147 |
| GSK | 7 | $129 |
| Mylan Specialty L.p. | 7 | $126 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $101 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $65 |
| Sanofi-aventis U.S. LLC | 2 | $53 |
| Johnson & Johnson | 3 | $52 |
| Almatica Pharma LLC | 2 | $50 |
| E.r. Squibb & Sons, L.L.C. | 2 | $41 |
| Insmed, Inc. | 2 | $36 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $28 |
| Verona Pharma, Inc. | 1 | $27 |
| Merck | 1 | $24 |
| Abbott | 1 | $23 |
| Biohaven Pharmaceuticals, Inc. | 1 | $23 |
| Arbor Pharmaceuticals, Inc. | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $15 |
How this compares
$4,809 in reported general payments places this provider in the 90th percentile of 8,062 physician assistant providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 31 | $52,335 |
| MounjaroTirzepatide | 38 | $39,387 |
| EliquisApixaban | 28 | $34,027 |
| XareltoRivaroxaban | 13 | $13,841 |
| Olmesartan Medoxomil | 60 | $2,129 |
| Alprazolam | 305 | $1,893 |
| Levothyroxine Sodium | 134 | $1,667 |
| Pantoprazole Sodium | 88 | $1,565 |
| Amlodipine Besylate | 173 | $1,452 |
| Rosuvastatin Calcium | 126 | $1,254 |
| Zolpidem Tartrate | 97 | $1,197 |
| Gabapentin | 43 | $1,113 |
| Escitalopram Oxalate | 69 | $1,050 |
| Temazepam | 67 | $1,037 |
| Atorvastatin Calcium | 140 | $995 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $418 | $52,33531 claims |
| Lilly USA, LLCMounjaro | $314 | $39,38738 claims |
| PfizerEliquis | $422 | $34,02728 claims |
| Johnson & JohnsonXarelto | $52 | $13,84113 claims |
| AbbVieSynthroid | $799 | $91516 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,062 physician assistant providers in Florida.
Other physician assistant in Boca Raton
- Wendy Yen MendezBoca Raton$116K
- Richard MarshallPort Orange$988K
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.